Drugs / DTG
last change Feb 2019 re-read 2 minutes ago

DTG

Developed for
HIV infectious disease
Investigated by
Gilead Sciences

Trials 1 · a red edge is where a trial was stopped

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02397694 Mar → Nov 2015 HIV infectious disease Gilead Sciences Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DTG ClinicalTrials.gov intervention name — accepted as the source's own label NCT02397694